Cargando…
IL-2 TUMOR TREATING FIELDS: IMPROVING THE ODDS FOR PATIENTS WITH GLIOBLASTOMA
Tumor treating fields (TTFields) is a novel, noninvasive regional antimitotic treatment modality approved for use in newly diagnosed glioblastoma (GBM). Nowadays, it is an integral part of the standard management of GBM. TTFields therapy delivers intermediate frequency (100-300 kHz), low intensity (...
Autor principal: | Hottinger, Andreas F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719296/ http://dx.doi.org/10.1093/noajnl/vdac167.111 |
Ejemplares similares
-
Tumor Treating Fields for Glioblastoma Therapy During the COVID-19 Pandemic
por: Gatson, Na Tosha N., et al.
Publicado: (2021) -
Tumor treating fields: a novel treatment modality and its use in brain tumors
por: Hottinger, Andreas F., et al.
Publicado: (2016) -
Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients with Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial
por: Ram, Zvi, et al.
Publicado: (2021) -
Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial
por: Ram, Zvi, et al.
Publicado: (2022) -
COVD-17. TUMOR TREATING FIELDS FOR GLIOBLASTOMA THERAPY DURING THE COVID-19 PANDEMIC: EXPERT CONSENSUS ON USE AND EXPERIENCE
por: Tosha Gatson, Na, et al.
Publicado: (2020)